Evidence map›Paper›PMID 24855369›Full record

ArticleSubstance abuse : research and treatment2014

Pregnancy and fetal loss reported by methamphetamine-using women.

Mary-Lynn Brecht, Diane M Herbeck

Open access · goldAbstract read
In one paragraph

Article in Substance abuse : research and treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Review
  6. Article
  7. An environmental scan of impacts and interventions for women with methamphetamine use in pregnancy and their children.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021
    Review
  8. Voluntary Pregnancy Screening at Syringe Exchanges: A Feasibility Study.Journal of prevention and health promotion · 2021
    Article
  9. Review
  10. Article
  11. Substance use during pregnancy.F1000Research · 2016
    Review
  12. Substance Use in the Perinatal Period.Current psychiatry reports · 2015
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mary-Lynn BrechtIntegrated Substance Abuse Programs, Department of Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA. ; School of Nursing, University of California, Los Angeles, California, USA.
Diane M HerbeckIntegrated Substance Abuse Programs, Department of Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
University of California, Los Angeles · US

Funding

STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
Methamphetamine Abuse: Long-Term Trajectories, Correlates, Treatment EffectsR01DA025113 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRECHT, MARY-LYNN · 2009 to 2012
$2.3M
METHAMPHETAMINE ABUSE--NATURAL HISTORY,TREATMENT EFFECTSR01DA011020 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRECHT, MARY-LYNN · 1998 to 2003
$1.9M
NIDA NIH HHS P30 DA016383NIDA NIH HHS R01 DA011020NIDA NIH HHS R01 DA025113
6 · The paper itself

Abstract

To better understand substance use disorder treatment needs of pregnant and parenting women who use methamphetamine (MA), this paper describes pregnancy histories and fetal losses for women who were treated for MA use (N = 153) with reference to a national sample, and describes their drug use, sexual risk behaviors, and mental health status. MA users reported an average of 4.6 total pregnancies and 2.1 fetal losses, whereas women in a general population survey reported 3.2 and 1.2, respectively. Higher numbers of pregnancies and fetal losses were correlated with specific substance abuse and mental health problems including early sexual abuse and cognitive problems. The combination of MA users' especially high numbers of pregnancies, fetal losses, and rates of risk behaviors suggest high social and health care costs for this population. Prenatal care may provide a vector through which women can be connected to risk reduction interventions and gender-responsive treatment services addressing substance use and mental health needs.

Indexed as

fetal lossmethamphetaminepregnancysubstance abuse treatment

Identifiers

PMID24855369
PMCPMC4011724
OpenAlexW2046961509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.